Albuvirtide for Injection.

Abovirta usually refers to Abovirta for injection. Abovirta for injection is a drug for the treatment of acquired immunodeficiency syndrome.
Acquired immunodeficiency syndrome is caused by human immunodeficiency virus infection. It is a Class B infectious disease and is contagious. It can cause others to be infected through sexual contact, mother-to-child transmission, etc., and damage the body’s immune system. For this disease, Abovirta for injection can generally be used for treatment. Abovirta for injection is a human immunodeficiency virus fusion inhibitor that can inhibit the fusion of the viral envelope and the human cell membrane, thereby blocking the replication of the virus. It is suitable for use in combination with other antiretroviral drugs, and can generally significantly improve the quality of life of patients.
It is recommended that patients use the drug in a standardized manner under the guidance of a doctor to obtain better treatment effects.